Verena Schildgen

1.7k total citations
65 papers, 1.0k citations indexed

About

Verena Schildgen is a scholar working on Epidemiology, Infectious Diseases and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Verena Schildgen has authored 65 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Epidemiology, 36 papers in Infectious Diseases and 19 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Verena Schildgen's work include Respiratory viral infections research (30 papers), Viral gastroenteritis research and epidemiology (20 papers) and Parvovirus B19 Infection Studies (14 papers). Verena Schildgen is often cited by papers focused on Respiratory viral infections research (30 papers), Viral gastroenteritis research and epidemiology (20 papers) and Parvovirus B19 Infection Studies (14 papers). Verena Schildgen collaborates with scholars based in Germany, United States and United Kingdom. Verena Schildgen's co-authors include Oliver Schildgen, Jessica Lüsebrink, Michael Brockmann, Ramona Liza Tillmann, Catherine Manoha, Monika Malecki, Bernadette van den Hoogen, John D. Williams, Ron A. M. Fouchier and Ralph A. Tripp and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and PLoS ONE.

In The Last Decade

Verena Schildgen

63 papers receiving 1.0k citations

Peers

Countries citing papers authored by Verena Schildgen

Since Specialization

Citations

This map shows the geographic impact of Verena Schildgen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Verena Schildgen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Verena Schildgen more than expected).

Fields of papers citing papers by Verena Schildgen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Verena Schildgen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Verena Schildgen. The network helps show where Verena Schildgen may publish in the future.

Co-authorship network of co-authors of Verena Schildgen

This figure shows the co-authorship network connecting the top 25 collaborators of Verena Schildgen. A scholar is included among the top collaborators of Verena Schildgen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Verena Schildgen. Verena Schildgen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Twenty years of human bocavirus research: from an unculturable virus of unclear pathogenicity to a culturable human pathogen and gene therapy vector candidate 2025 ·Clinical Microbiology Reviews ·Oliver Schildgen, Jianming Qiu, Mario Mietzsch, Tobias Allander, Tuomas Jartti, Verena Schildgen, Dirk Grimm, Maria Söderlund‐Venermo	0
2	Direct comparison of Altona-SARS-CoV-2 dual target RT-qPCR Assay with commercial LAMP Assay using throat washes in health care staff testing 2022 ·SHILAP Revista de lepidopterología ·(unknown), Jessica Lüsebrink, (unknown), (unknown), Verena Schildgen, Oliver Schildgen	2
3	Comparison of Biocartis IDYLLA ™ cartridge assay with Qiagen GeneReader NGS for detection of targetable mutations in EGFR, KRAS/NRAS, and BRAF genes 2021 ·Experimental and Molecular Pathology ·(unknown), Michael Brockmann, (unknown), (unknown), Jessica Lüsebrink, Verena Schildgen, Oliver Schildgen	5
4	Renal transplantation after recovery from COVID-19 - a case report with implications for transplant programs in the face of the ongoing corona-pandemic 2021 ·BMC Nephrology ·(unknown), (unknown), (unknown), Verena Schildgen, Oliver Schildgen, Jan U. Becker, Alexander Weidemann	3
5	Pooling is an insufficient strategy to avoid healthcare staff to patient transmission of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) 2020 ·Infection Control and Hospital Epidemiology ·Jessica Lüsebrink, Verena Schildgen, Oliver Schildgen	2
6	Oncotype DX Breast Cancer recurrence score resists inter-assay reproducibility with RT2-Profiler Multiplex RT-PCR 2019 ·Scientific Reports ·Verena Schildgen, Mathias Warm, Michael Brockmann, Oliver Schildgen	8
7	Novel Chimeric Gene Therapy Vectors Based on Adeno-Associated Virus and Four Different Mammalian Bocaviruses 2019 ·Molecular Therapy — Methods & Clinical Development ·Julia Fakhiri, Marc A. Schneider, Jens Puschhof, Megan L. Stanifer, Verena Schildgen, (unknown), (unknown), Jihad El Andari, Oliver Schildgen, Steeve Boulant, Michael Meister, Hans Clevers, Ziying Yan, Jianming Qiu, Dirk Grimm	42
8	NGS-dataset of putative driver mutations associated with benign peritoneal strumosis 2018 ·Data in Brief ·Michael Brockmann, Verena Schildgen, Oliver Schildgen, Jessica Lüsebrink, (unknown), Alexandru Gudima	2
9	Pre-clinical validation of a next generation sequencing testing panel 2018 ·Experimental and Molecular Pathology ·Jessica Lüsebrink, (unknown), (unknown), Michael Brockmann, Oliver Schildgen, Verena Schildgen	5
10	Fatal HBoV-1 infection in adult female cystic fibrosis patient 2016 ·Human Pathology Case Reports ·(unknown), Christian Karagiannidis, Stephan Straßmann, (unknown), (unknown), Joseph Zabner, Aloysius J. Klingelhutz, Wolfram Windisch, Michael Brockmann, Oliver Schildgen, Verena Schildgen	3
11	Case Report 2015 ·Medicine ·(unknown), Kathrin Gerbershagen, (unknown), (unknown), Michael Brockmann, Verena Schildgen, (unknown), Volker Limmroth, Arno J. Dormann, Oliver Schildgen	6
12	Pneumocystis jirovecii Can Be Productively Cultured in Differentiated CuFi-8 Airway Cells 2014 ·mBio ·Verena Schildgen, (unknown), (unknown), Jessica Lüsebrink, (unknown), Ramona Liza Tillmann, Michael Brockmann, Oliver Schildgen	55
13	How is a molecular polymorphism defined? 2013 ·Cancer ·Verena Schildgen, Oliver Schildgen	3
14	The Human Bocavirus Is Associated with Some Lung and Colorectal Cancers and Persists in Solid Tumors 2013 ·PLoS ONE ·Verena Schildgen, Monika Malecki, (unknown), Michael Brockmann, Oliver Schildgen	47
15	Identification of Uncommon PIK3CA Mutations in Lung Cancer by Using Pyrosequencing 2013 ·Diagnostic Molecular Pathology ·Verena Schildgen, Jessica Lüsebrink, (unknown), (unknown), Walburga Engel-Riedel, Corinna Ludwig, Erich Stoelben, Oliver Schildgen, Michael Brockmann	5
16	Comparison of Two Commercial PCR Methods for Methicillin-Resistant Staphylococcus aureus (MRSA) Screening in a Tertiary Care Hospital 2012 ·PLoS ONE ·(unknown), Jessica Lüsebrink, Verena Schildgen, (unknown), (unknown), K Schwarz, Sabine Messler, Oliver Schildgen, Frauke Mattner	10
17	Impaired mitochondrial gene transcription in myelodysplastic syndromes and acute myeloid leukemia with myelodysplasia-related changes 2011 ·Experimental Hematology ·Verena Schildgen, Michael Wulfert, Norbert Gattermann	24
18	Respiratory Infections by HMPV and RSV Are Clinically Indistinguishable but Induce Different Host Response in Aged Individuals 2011 ·PLoS ONE ·Vanessa Ditt, Jessica Lüsebrink, Ramona Liza Tillmann, Verena Schildgen, Oliver Schildgen	22
19	Detection of Head-to-Tail DNA Sequences of Human Bocavirus in Clinical Samples 2011 ·PLoS ONE ·Jessica Lüsebrink, Verena Schildgen, Ramona Liza Tillmann, (unknown), Anne C. Böhmer, Andreas Müller, Oliver Schildgen	60
20	Does human bocavirus infection depend on helper viruses? A challenging case report 2011 ·Virology Journal ·(unknown), Monika Malecki, Aram Prokop, Verena Schildgen, Jessica Lüsebrink, (unknown), (unknown), Michael D. Weiss, Reinhold Cremer, Michael Brockmann, Oliver Schildgen	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact